Vanda Pharmaceuticals (VNDA) Gross Margin Growth (3y) (2017 - 2026)
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Gross Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 569.00 |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | 55.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 |
| Mar 31, 2026 | 153.00 |
| Dec 31, 2025 | 297.00 |
| Sep 30, 2025 | 442.00 |
| Jun 30, 2025 | 421.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 430.00 |
| Sep 30, 2024 | 434.00 |
| Jun 30, 2024 | 426.00 |
| Mar 31, 2024 | 237.00 |
| Dec 31, 2023 | 183.00 |
| Sep 30, 2023 | 189.00 |
| Jun 30, 2023 | 180.00 |
| Mar 31, 2023 | 134.00 |
| Dec 31, 2022 | 54.00 |
| Sep 30, 2022 | 173.00 |
| Jun 30, 2022 | 137.00 |
| Mar 31, 2022 | 130.00 |
| Dec 31, 2021 | 152.00 |
| Sep 30, 2021 | 62.00 |